Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ technology to make permanent alterations to the human genome, aiming to cure diseases and advance genome engineering.
Joint Base Lewis McChord
Washington
Notice Date
October 31, 2025
November 1, 2025
Unavailable
Temporary
Layoff
SEIU
More WARN Notices from
